Stay updated on Iomab-B vs Conventional Care in Older AML Clinical Trial
Sign up to get notified when there's something new on the Iomab-B vs Conventional Care in Older AML Clinical Trial page.

Latest updates to the Iomab-B vs Conventional Care in Older AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's footer revision label was updated to v3.5.4 (from v3.5.3), signaling a minor metadata update to the page. No substantive study content or data are affected.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site software or UI update rather than a change to the underlying study record.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision v3.5.2 was added and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.3 was added. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check111 days agoChange DetectedAdded system revision tag 'Revision: v3.4.2' and removed an informational banner about government funding and operating status. These are administrative UI updates that do not impact study data or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Iomab-B vs Conventional Care in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iomab-B vs Conventional Care in Older AML Clinical Trial page.